fda approval of biosimilar, proposed change in us drug prices, and 2018 asco presscast
Published 6 years ago • 246 plays • Length 10:13Download video MP4
Download video MP3
Similar videos
-
1:58
fda review and approval process for biosimilar medications
-
2:47
biosimilars: approval process
-
8:31
fda d.i.s.c.o.: first biosimilar approval for the treatment of cancer
-
1:36
interchangeable biosimilars
-
5:20
data requirements for biosimilars
-
39:17
use of phoenix to calculate abe and pbe for in vitro data of inhaled products
-
3:33
biosimilars: manufacturing and inherent variation
-
3:00
biosimilars: complex copycat drugs
-
2:04
the impact of the fda's approval of the first 'biosimilar' drug
-
6:18
fda approves of biosimilar to infliximab – ibd in the news
-
1:55
dr. hurvitz on the fda approval process for biosimilars
-
22:48
navigating the world of biosimilar user fees- june 10, 2019
-
3:07
the promise of biosimilars
-
4:20
the biosimilar development process
-
6:41
fda approval in pmbcl, european approval in all, and 2018 eha congress highlights
-
59:48
generic drugs and biosimilars 101
-
24:48
fda perspectives on biosimilar bla-manufacturing (28of33) quality – oct. 16-17, 2019
-
3:02
biosimilar medications — what patients need to know
-
1:02
dr. mitri on impact of trastuzumab biosimilar fda approval
-
1:32:09
biosimilar generic biologics in the usa approval pathway
-
14:31
biosimilars and interchangeables - regulatory highlights (27of33) quality – oct. 16-17, 2019
-
0:16
biosimilar medications: as identical twins explain, biosimilars have the same benefits (15 sec.)